These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 33139116)

  • 1. Complement activation and endothelial perturbation parallel COVID-19 severity and activity.
    Cugno M; Meroni PL; Gualtierotti R; Griffini S; Grovetti E; Torri A; Lonati P; Grossi C; Borghi MO; Novembrino C; Boscolo M; Uceda Renteria SC; Valenti L; Lamorte G; Manunta M; Prati D; Pesenti A; Blasi F; Costantino G; Gori A; Bandera A; Tedesco F; Peyvandi F
    J Autoimmun; 2021 Jan; 116():102560. PubMed ID: 33139116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis.
    Andrianto ; Al-Farabi MJ; Nugraha RA; Marsudi BA; Azmi Y
    Microvasc Res; 2021 Nov; 138():104224. PubMed ID: 34273359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes.
    Fernández S; Moreno-Castaño AB; Palomo M; Martinez-Sanchez J; Torramadé-Moix S; Téllez A; Ventosa H; Seguí F; Escolar G; Carreras E; Nicolás JM; Richardson E; García-Bernal D; Carlo-Stella C; Moraleda JM; Richardson PG; Díaz-Ricart M; Castro P
    Shock; 2022 Jan; 57(1):95-105. PubMed ID: 34172614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.
    Peerschke EI; Valentino A; So RJ; Shulman S; Ravinder
    Front Immunol; 2021; 12():716361. PubMed ID: 34491250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.
    Goshua G; Pine AB; Meizlish ML; Chang CH; Zhang H; Bahel P; Baluha A; Bar N; Bona RD; Burns AJ; Dela Cruz CS; Dumont A; Halene S; Hwa J; Koff J; Menninger H; Neparidze N; Price C; Siner JM; Tormey C; Rinder HM; Chun HJ; Lee AI
    Lancet Haematol; 2020 Aug; 7(8):e575-e582. PubMed ID: 32619411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality.
    Philippe A; Chocron R; Gendron N; Bory O; Beauvais A; Peron N; Khider L; Guerin CL; Goudot G; Levasseur F; Peronino C; Duchemin J; Brichet J; Sourdeau E; Desvard F; Bertil S; Pene F; Cheurfa C; Szwebel TA; Planquette B; Rivet N; Jourdi G; Hauw-Berlemont C; Hermann B; Gaussem P; Mirault T; Terrier B; Sanchez O; Diehl JL; Fontenay M; Smadja DM
    Angiogenesis; 2021 Aug; 24(3):505-517. PubMed ID: 33449299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation.
    Ward SE; Curley GF; Lavin M; Fogarty H; Karampini E; McEvoy NL; Clarke J; Boylan M; Alalqam R; Worrall AP; Kelly C; de Barra E; Glavey S; Ni Cheallaigh C; Bergin C; Martin-Loeches I; Townsend L; Mallon PW; O'Sullivan JM; O'Donnell JS;
    Br J Haematol; 2021 Feb; 192(4):714-719. PubMed ID: 33326604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection.
    Francischetti IMB; Toomer K; Zhang Y; Jani J; Siddiqui Z; Brotman DJ; Hooper JE; Kickler TS
    EClinicalMedicine; 2021 Sep; 39():101069. PubMed ID: 34377969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial biomarkers (Von willebrand factor, BDCA3, urokinase) as predictors of mortality in COVID-19 patients: cohort study.
    Sánchez-Santillán RN; Sierra-Vargas MP; González-Islas D; Aztatzi-Aguilar OG; Pérez-Padilla R; Orea-Tejeda A; Debray-García Y; Ortega-Romero M; Keirns-Davis C; Loaeza-Roman A; Rios-Pereda A
    BMC Pulm Med; 2024 Jul; 24(1):325. PubMed ID: 38965511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins.
    Bombeli T; Jutzi M; De Conno E; Seifert B; Fehr J
    Blood Coagul Fibrinolysis; 2002 Oct; 13(7):577-81. PubMed ID: 12439142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.
    Holter JC; Pischke SE; de Boer E; Lind A; Jenum S; Holten AR; Tonby K; Barratt-Due A; Sokolova M; Schjalm C; Chaban V; Kolderup A; Tran T; Tollefsrud Gjølberg T; Skeie LG; Hesstvedt L; Ormåsen V; Fevang B; Austad C; Müller KE; Fladeby C; Holberg-Petersen M; Halvorsen B; Müller F; Aukrust P; Dudman S; Ueland T; Andersen JT; Lund-Johansen F; Heggelund L; Dyrhol-Riise AM; Mollnes TE
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):25018-25025. PubMed ID: 32943538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study.
    Bruni F; Charitos P; Lampart M; Moser S; Siegemund M; Bingisser R; Osswald S; Bassetti S; Twerenbold R; Trendelenburg M; Rentsch KM; Osthoff M
    Front Immunol; 2022; 13():941742. PubMed ID: 36203596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
    Meroni PL; Croci S; Lonati PA; Pregnolato F; Spaggiari L; Besutti G; Bonacini M; Ferrigno I; Rossi A; Hetland G; Hollan I; Cugno M; Tedesco F; Borghi MO; Salvarani C
    Autoimmun Rev; 2023 Jan; 22(1):103232. PubMed ID: 36414219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state.
    Henry BM; Szergyuk I; de Oliveira MHS; Lippi G; Benoit JL; Vikse J; Benoit SW
    J Med Virol; 2021 Sep; 93(9):5515-5522. PubMed ID: 33974276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
    Freestone B; Chong AY; Nuttall S; Blann AD; Lip GY
    Chest; 2007 Oct; 132(4):1253-8. PubMed ID: 17890461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19.
    Valenti L; Griffini S; Lamorte G; Grovetti E; Uceda Renteria SC; Malvestiti F; Scudeller L; Bandera A; Peyvandi F; Prati D; Meroni P; Cugno M
    J Autoimmun; 2021 Feb; 117():102595. PubMed ID: 33453462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection.
    Lopez-Castaneda S; García-Larragoiti N; Cano-Mendez A; Blancas-Ayala K; Damian-Vázquez G; Perez-Medina AI; Chora-Hernández LD; Arean-Martínez C; Viveros-Sandoval ME
    Clin Appl Thromb Hemost; 2021; 27():1076029621999099. PubMed ID: 33835872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation is associated with poor outcome after out-of-hospital cardiac arrest.
    Chaban V; Nakstad ER; Stær-Jensen H; Schjalm C; Seljeflot I; Vaage J; Lundqvist C; Benth JŠ; Sunde K; Mollnes TE; Andersen GØ; Pischke SE
    Resuscitation; 2021 Sep; 166():129-136. PubMed ID: 34126135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial injury in COVID-19 and septic patients.
    Hokama LT; Veiga ADM; Menezes MCS; Sardinha Pinto AA; de Lima TM; Ariga SKK; Barbeiro HV; Barbeiro DF; de Lucena Moreira C; Stanzani G; Brandao RA; Marchini JF; Alencar JC; Marino LO; Gomez LM; ; Souza HP
    Microvasc Res; 2022 Mar; 140():104303. PubMed ID: 34914941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.